- 脂質低下の、脂質低下性の
WordNet
- a medicine that lowers blood cholesterol levels by inhibiting HMG-CoA reductase (同)lipid-lowering medication, statin drug, statin
- (botany) either of the two parts of a bilabiate corolla or calyx
- either the outer margin or the inner margin of the aperture of a gastropods shell
- either of two fleshy folds of tissue that surround the mouth and play a role in speaking
- the act of causing something to move to a lower level (同)letting down
- the act of causing to become less
- an oily organic compound insoluble in water but soluble in organic solvents; essential structural component of living cells (along with proteins and carbohydrates) (同)lipide, lipoid
PrepTutorEJDIC
- 〈C〉『くちびる』,口もと / 《複数形で》(発音器官としての)くちびる,口 / 〈U〉《俗》生意気な言葉 / 〈C〉(容器などの)口,へり,縁;(峡谷・火山などの)口 / 〈C〉(植物の)唇弁(しんべん)
- 低くする,低下させる;堕落させる
- (空模様が)険悪な,荒れ模様の / しかめっつらの,(顔つきが)不機嫌な
- 脂質,あぶら
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. スタチン系およびフィブラート系以外の薬剤による脂質低下 lipid lowering with drugs other than statins and fibrates
- 2. 食事または栄養補助食品による脂質低下 lipid lowering with diet or dietary supplements
- 3. 高脂血症治療剤が関連した筋損傷 muscle injury associated with lipid lowering drugs
- 4. フィブラート系薬剤による脂質低下 lipid lowering with fibric acid derivatives
- 5. 二次予防における脂質（高コレステロール血症を含む）の治療 treatment of lipids including hypercholesterolemia in secondary prevention
English Journal
- Using quantile regression to assess disparities in medication adherence.
- Juarez DT, Tan C, Davis JW, Mau MM.SourceCollege of Pharmacy, University of Hawaii, Hilo, HI, USA. dtjuarez@hawaii.edu.
- American journal of health behavior.Am J Health Behav.2014 Jan;38(1):53-62. doi: 10.5993/AJHB.38.1.6.
- OBJECTIVE: To examine racial/ethnic disparities in medication adherence between Asian and Pacific Islander Americans and Whites.METHODS: This retrospective data analysis included diabetes patients enrolled in a health plan in Hawaii (N = 43,445). For anti-diabetic, lipid-lowering, and anti-hypertens
- PMID 24034680
- Stroke subtypes and interventional studies for transient ischemic attack.
- Lavallée P, Amarenco P.SourceINSERM U-698, Department of Neurology and Stroke Center, AP-HP, Bichat-Claude Bernard Hospital, University Paris Diderot, Sorbonne Paris Cité, Paris, France.
- Frontiers of neurology and neuroscience.Front Neurol Neurosci.2014;33:135-46. doi: 10.1159/000351914. Epub 2013 Oct 11.
- Transient ischemic attack (TIA) is the most important risk factor for ischemic stroke. The risk is the highest in the first hours after symptom onset, and treatment must be initiated in emergency. In the acute phase, antithrombotic agent is probably the most important treatment, but it is not exclud
- PMID 24157562
- Effect of a GFOD2 variant on responses in total and LDL cholesterol in Mexican subjects with hypercholesterolemia after soy protein and soluble fiber supplementation.
- Guevara-Cruz M, Lai CQ, Richardson K, Parnell LD, Lee YC, Tovar AR, Ordovás JM, Torres N.SourceDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F., México.
- Gene.Gene.2013 Dec 15;532(2):211-5. doi: 10.1016/j.gene.2013.09.055. Epub 2013 Sep 21.
- BACKGROUND: Although dietary treatments can successfully reduce blood lipids in hypercholesterolemic subjects, individual variation in that response has on occasion been linked to allelic differences. SNP rs12449157 has shown association with HDL-C concentrations in GWAS and falls in the glucose-fru
- PMID 24064143
Japanese Journal
- Effect of Combination Therapy of Ezetimibe and Rosuvastatin on Regression of Coronary Atherosclerosis in Patients With Coronary Artery Disease
- , , , , , , , , , , , ,
- International Heart Journal advpub(0), 2015
- … Moreover, percent change in PV showed positive correlations with percent change of LDL-C (r = 0.384, P = 0.015).Intensive lipid-lowering therapy with ezetimibe added to usual-dose statin may provide significant incremental reduction in coronary plaques compared with usual-dose statin monotherapy. …
- NAID 130005066380
- Lipid Lowering in Patients With Kidney Disease – Is It Really That Hard? –
- ,
- Circulation Journal 79(5), 976-977, 2015
- NAID 130005066276
- The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis
- , , , , , , , ,
- Internal Medicine 54(8), 887-894, 2015
- … Objective Although lipid disorders are a well-known risk factor for cardiovascular disease (CVD) in the general population, the optimal management with lipid-lowering therapy to reduce CVD risks and mortality in hemodialysis (HD) patients remains controversial. … In the clinical setting, dyslipidemia can be diagnosed based on the detection of elevated lipid concentrations at the beginning of HD. …
- NAID 130005065272
Related Links
- 用 語 対 訳 lipid 脂質、リピッド lipid core リピッドコア lipid lowering 脂質低下 lipid-lowering agent 脂質低下薬 lipid-lowering diet 脂質低下食 lipid-lowering therapy 脂質低下療法 lipid metabolism 脂質代謝 lipid profile 脂質プロフィール
- lipid lowering 脂肪低下 - アルクがお届けする進化するオンライン英和・和英辞書データベース。一般的な単語や連語から、イディオム、専門用語、スラングまで幅広く収録。
Related Pictures
★リンクテーブル★
| リンク元 | 「hypolipidemic」「脂質低下」「脂質低下性」 |
| 拡張検索 | 「lipid-lowering drug」「lipid-lowering agent」 |
| 関連記事 | 「lowering」「lip」 |
「hypolipidemic」
- adj.
- 脂質低下性の、脂質低下の
- n.
- 関
- antilipemic agent、antilipemic drug、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering、lipid-lowering agent、lipid-lowering drug
「脂質低下」
「脂質低下性」
「lipid-lowering drug」
- 関
- antilipemic agent、antilipemic drug、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering agent
「lipid-lowering agent」
- 関
- antilipemic agent、antilipemic drug、hypolipidemic、hypolipidemic agent、hypolipidemic drug、hypolipidemics、lipid-lowering drug
「lowering」
- n.
- 低下、低減
「lip」
- n.